Title : Risk factors of impaired humoral response to COVID-19 vaccination in rituximab treated patients.

Pub. Date : 2021 Nov 2

PMID : 34726701






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The effect of RTX and Methotrexate was additive in terms of seroconversion rates (23% vs 50% in patients receiving RTX in monotherapy, p= 0.12) and SARS-CoV-2 spike antibody levels (3.80 AU/ml, 95% confidence interval, CI 3.80-7.50 AU/ml vs 75 AU/ml, 95% CI 3.8-353 AU/ml in patients receiving RTX in monotherapy p= 0.025). Methotrexate surface glycoprotein Severe acute respiratory syndrome coronavirus 2